Insurer Files Class Action Against Shkreli, Others For Daraprim Monopoly

Mealey's (March 17, 2021, 9:51 AM EDT) -- NEW YORK — Blue Cross and Blue Shield of Minnesota (BCBSM) on March 4 filed a nationwide class action against two drug companies and two former executives, including Martin Shkreli, in Pennsylvania federal court, alleging that the defendants conspired to create and maintain a monopoly for the drug Daraprim XE "Daraprim"  and to raise the drug’s price from $17.50 per tablet to $750 per tablet....

Attached Documents

Related Sections